Trial
NCT01332617
Phase II Study of Simvastatin for Relapsed/Refractory Myeloma
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Louisville
Collaborators
James Graham Brown Cancer Center
Condition
Myeloma
Intervention
Simvastatin,Zoledronic Acid,Bortezomib,Bendamustine,Methylprednisolone.
Why stopped
Investigators no longer interested in activating study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-12-29